203. Phase I Study of the “Triad” Autologous (FANG™) Vaccine, Incorporating Bifunctional shRNAfurin and GMCSF Transgene Expression, in Advanced Ewing's Sarcoma: Preliminary Data in Pediatrics Patients

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)34538-5
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

331. Phase I Study of the “Triad” Autologous (FANG™) Vaccine, Incorporating Bifunctional shRNAfurin and GMCSF Transgene Expression, in Advanced Cancer Patients

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

206. FANG™ Cytokine Expression Analyses Update

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Ewing's Sarcoma of the Hand

BMJ Case Reports
Medicine
2014English

A Phase I Study of Indoximod in Patients With Advanced Malignancies

Oncotarget
Oncology
2016English

Phase I Study of Temozolomide in Paediatric Patients With Advanced Cancer

British Journal of Cancer
Cancer ResearchOncology
1998English

Prediction of High Risk Ewing's Sarcoma by Gene Expression Profiling

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

666. Phase I Study Results of Pbi-shRNA™ STMN1 Nanoplex via Intratumoral Injection in Advanced Cancer

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

A Phase II Study of Docetaxel in Patients With Relapsed and Refractory Ewing's Tumours

Sarcoma
Nuclear MedicineRadiologyImagingOncology
2003English

Imaging Findings of Ewing's Sarcoma in the Mandible

Journal of oral science
MedicineDentistry
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy